• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    7/14/23 12:53:59 PM ET
    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electrical Products
    Industrials
    Get the next $ACAD alert in real time by email

    Gainers

    • PainReform Ltd. (NASDAQ:PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
    • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares climbed 46.3% to $63.24 after jumping 203% on Thursday.
    • Frequency Therapeutics, Inc. (NASDAQ:FREQ) gained 41.7% to $0.5669 after the company agreed to merge with Korro Bio in an all- stock transaction.
    • Ainos, Inc. (NASDAQ:AIMD) surged 38% to $1.0082.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) gained 33.4% to $6.15.
    • Envirotech Vehicles, Inc. (NASDAQ:EVTV) climbed 29.2% to $3.10.
    • Monopar Therapeutics Inc. (NASDAQ:MNPR) rose 25% to $1.0699.
    • Chijet Motor Company, Inc. (NASDAQ:CJET) climbed 21.1% to $3.7738. Chijet Motor Company's majority-owned subsidiary achieved a breakthrough in export model.
    • Canoo Inc. (NASDAQ:GOEV) gained 21.1% to $0.6728.
    • Western Acquisition Ventures Corp. (NASDAQ:WAVS) gained 18.2% to $12.28.
    • ARB IOT Group Limited (NASDAQ:ARBB) shares rose 18% to $3.84 after gaining around 12% on Thursday.
    • TMC the metals company Inc. (NASDAQ:TMC) climbed 16.7% to $2.1250.
    • ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gained 15.6% to $29.83. Acadia Pharmaceuticals acquired ex-North American rights to trofinetide and global rights to Neuren's NNZ-2591 in Rett syndrome and Fragile X syndrome.
    • Aehr Test Systems (NASDAQ:AEHR) gained 14.4% to $47.80 as the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 revenue to be at least $100 million and GAAP net income of at least $28 million.
    • 1847 Holdings LLC (NYSE:EFSH) rose 14% to $0.2850. 1847 projects revenue of $20 million for the second quarter.
    • Nutriband Inc. (NASDAQ:NTRB) gained 13.6% to $2.7299. Nutriband increased existing credit line to $5 million supporting the continued development of its AVERSA platform towards FDA submission.
    • Nikola Corporation (NASDAQ:NKLA) shares rose 13.1% to $2.5115 after gaining over 60% on Thursday. The company and BayoTech announced an agreement to advance reliable hydrogen supply for zero-emission commercial fuel cell electric vehicle fleets.
    • Ambow Education Holding Ltd. (NYSE:AMBO) gained 13% to $0.2293.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 12% to $34.52. Cantor Fitzgerald reiterated Arcturus Therapeutics with an Overweight and maintained a $54 price target.
    • Elanco Animal Health Incorporated (NYSE:ELAN) gained 10.4% to $11.70 after the company announced the EPA completed its review of the Seresto collar and confirmed continued registration of the collar.
    • Shengfeng Development Limited (NASDAQ:SFWL) climbed 10.2% to $6.35.
    • Intuitive Machines, Inc. (NASDAQ:LUNR) shares rose 9.5% to $9.35. Intuitive Machines is closing in on delivering its Nova-C lunar lander to Florida for launch. The company said on Thursday that it has successfully conducted a complete spacecraft test run of the lander.
    • GT Biopharma, Inc. (NASDAQ:GTBP) shares gained 8.1% to $0.3039.
    • Ainos, Inc. (NASDAQ:AIMD) gained 37% to $1.0001 after gaining around 7% on Thursday.

    Losers

    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) shares dipped 69.9% to $2.87 after the company announced discontinuing enrollment in Phase 1/2 study and terminating development of THE-630 for gastrointestinal stromal tumors following two dose-limiting toxicities.
    • Canopy Growth Corporation (NASDAQ:CGC) fell 37% to $0.4088. Cannabis company announced it has entered into a series of agreements, including privately negotiated redemption agreements with certain holders of its unsecured senior notes due July 15, 2023 (the "existing notes") and agreements with certain of its lenders under its term loan credit agreement dated March 18, 2021, that will have the overall effect of deleveraging the company's balance sheet.
    • Leslie's, Inc. (NASDAQ:LESL) dropped 33.8% to $6.30 after the company released preliminary results for its fiscal third quarter and announced a CFO transition. The company said it expects fiscal third-quarter revenue to come in at $611 million versus estimates of $703.74 million and seed adjusted earnings in a range of 39 cents to 41 cents per share versus estimates of 69 cents per share. Leslie's also announced that CFO Steve Weddell is stepping down from his role, effective Aug. 7.
    • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) declined 30.3% to $1.45. Galmed Pharmaceuticals announced pricing of $7 million public offering of 5.6 million shares and warrants at a purchase price of $1.25 per share.
    • TELUS International (Cda) Inc. (NASDAQ:TIXT) fell 28.4% to $10.52 after the company issued FY23 adjusted EPS and revenue guidance below estimates.
    • Fresh Vine Wine, Inc. (NASDAQ:VINE) fell 26.6% to $0.4305 after gaining over 12% on Thursday.
    • Lilium N.V. (NASDAQ:LILM) fell 22% to $1.3200 after the company announced pricing of an upsized $192 million offering.
    • Organigram Holdings Inc. (NASDAQ:OGI) tumbled 21.6% to $1.5215 as the company released its results for the third quarter ended May 31, 2023, revealing net revenue decreased 14% to CA$32.8 million ($25 million), from CA$38.1 million in Q3 fiscal 2022.
    • Funko, Inc. (NASDAQ:FNKO) declined 21.5% to $7.90. Funko said Brian Mariotti will take leave of absence and cease serving as the company’s CEO.
    • Caribou Biosciences, Inc (NASDAQ:CRBU) fell 21.3% to $6.41. Caribou Biosciences announced pricing of its upsized $125 million public offering. The company also reported long-term follow-up data from the dose escalation portion of the ongoing ANTLER Phase 1 trial of CB-010, an allogeneic anti-CD19 CAR-T cell therapy for relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL).
    • Opera Limited (NASDAQ:OPRA) fell 21.3% to $21.91 after the company filed for a mixed shelf of up to $300 million.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares plunged 18.6% to $3.6886.
    • IT Tech Packaging, Inc. (NYSE:ITP) shares dipped 18.3% to $0.4250.
    • Rockwell Medical, Inc. (NASDAQ:RMTI) shares declined 17.5% to $3.39.
    • Frontier Communications Parent, Inc. (NASDAQ:FYBR) shares dipped 16.6% to $13.55.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) fell 16.3% to $3.60.
    • Inogen, Inc. (NASDAQ:INGN) fell 15% to $8.72. Needham downgraded Inogen from Buy to Hold.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) declined 14.8% to $3.45.
    • Bit Brother Limited (NASDAQ:BTB) fell 14.3% to $0.66 after the company announced pricing of a $50 million registered direct offering.
    • Ault Alliance, Inc. (NYSE:AULT) fell 14.1% to $3.6150 after declining over 20% on Thursday. Ault Alliance recently announced a second partial distribution of TOG Securities of approximately $0.37 for each share of Ault Alliance common stock.
    • CommScope Holding Company, Inc. (NASDAQ:COMM) shares fell 11.8% to $5.76.
    • CareMax, Inc. (NASDAQ:CMAX) fell 11.2% to $2.4250.
    • Beneficient (NASDAQ:BENF) shares fell 10.8% to $2.56.
    • Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) shares dropped 10.5% to $5.14 after the company posted a loss for the second quarter.
    • State Street Corporation (NYSE:STT) fell 10.5% to $69.18 after after the company reported slightly worse-than-expected second-quarter revenues as well as an increase in total expenses.
    • Nokia Oyj (NYSE:NOK) shares fell 10% to $3.9150 after the company reduced net sales guidance and narrowed its operating margin outlook for 2023.
    • Lumen Technologies, Inc. (NYSE:LUMN) shares slipped 9.9% to $1.8550.
    • D-Wave Quantum Inc. (NASDAQ:QBTS) shares declined 9.9% to $2.3697.
    • Hayward Holdings, Inc. (NYSE:HAYW) shares dipped 8.4% to $12.42.
    • Lumentum Holdings Inc. (NASDAQ:LITE) fell 7.7% to $51.32.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) fell 7% to $0.3265. Aridis recently announced FDA Qualified Infectious Disease Product Designation for AR-301.

     

    Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields

    Get the next $ACAD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAD
    $AEHR
    $AIMD
    $AMBO

    CompanyDatePrice TargetRatingAnalyst
    State Street Corporation
    $STT
    10/3/2025$130.00Outperform
    BMO Capital Markets
    State Street Corporation
    $STT
    9/25/2025Buy
    TD Cowen
    Monopar Therapeutics Inc.
    $MNPR
    9/9/2025$87.00Buy
    BTIG Research
    State Street Corporation
    $STT
    9/5/2025$130.00Neutral → Buy
    Citigroup
    Arcturus Therapeutics Holdings Inc.
    $ARCT
    9/4/2025$60.00Buy
    H.C. Wainwright
    Monopar Therapeutics Inc.
    $MNPR
    9/3/2025$77.00Outperform
    Oppenheimer
    Monopar Therapeutics Inc.
    $MNPR
    9/3/2025$80.00Strong Buy
    Raymond James
    Nokia Corporation Sponsored
    $NOK
    9/3/2025$5.00Neutral → Outperform
    BNP Paribas Exane
    More analyst ratings

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on State Street with a new price target

    BMO Capital Markets initiated coverage of State Street with a rating of Outperform and set a new price target of $130.00

    10/3/25 8:45:29 AM ET
    $STT
    Major Banks
    Finance

    TD Cowen initiated coverage on State Street

    TD Cowen initiated coverage of State Street with a rating of Buy

    9/25/25 8:34:15 AM ET
    $STT
    Major Banks
    Finance

    BTIG Research initiated coverage on Monopar Therapeutics with a new price target

    BTIG Research initiated coverage of Monopar Therapeutics with a rating of Buy and set a new price target of $87.00

    9/9/25 7:59:49 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: Chief Financial Officer Sassine Andy bought $20,499 worth of shares (1,238 units at $16.56), increasing direct ownership by 0.56% to 221,764 units (SEC Form 4)

    4/A - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)

    8/20/25 4:01:44 PM ET
    $ARCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Sassine Andy decreased direct ownership by 0.56% to 221,764 units (SEC Form 4)

    4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)

    8/19/25 4:05:30 PM ET
    $ARCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and CFO Vanhimbergen Robert M was granted 109,857 shares (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    10/3/25 5:10:36 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VP Contactor Business Unit Sporck Alistair N covered exercise/tax liability with 207 shares, decreasing direct ownership by 0.69% to 29,955 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    10/2/25 7:28:51 PM ET
    $AEHR
    Electrical Products
    Industrials

    CFO Siu Chris covered exercise/tax liability with 694 shares, decreasing direct ownership by 0.91% to 75,535 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    10/2/25 7:22:45 PM ET
    $AEHR
    Electrical Products
    Industrials

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    1847 Holdings Expects to Resume Trading on OTC Pink Limited Tier

    NEW YORK, NY, Oct. 03, 2025 (GLOBE NEWSWIRE) -- 1847 Holdings LLC ("1847" or the "Company") (Previous Ticker: EFSH), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle market businesses, today announced that it expects to begin trading on the OTC Pink Limited tier of OTC Markets Group Inc. within the next one-to-four business days, subject to FINRA's review of its requested trading symbol. Following the expected commencement of trading on the OTC Pink Limited tier, the Company intends to further enhance its market visibility by promptly transitioning to the OTCID. 1847's ultimate objective is to relist on a senior U.S. exchange as soon

    10/3/25 3:15:00 PM ET
    $EFSH
    Professional Services
    Consumer Discretionary

    WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $755,000

    JERSEY CITY, N.J., Oct. 3, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced today it has entered into warrant exercise agreements with certain existing accredited and institutional investors to exercise outstanding warrants to purchase an aggregate of 377,702 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of approximately

    10/3/25 1:20:00 PM ET
    $HCTI
    EDP Services
    Technology

    Opera's flagship and GX browsers to receive upgraded free, native browser AI tools

    OSLO, Norway, Oct. 3, 2025 /PRNewswire/ -- Opera (NASDAQ:OPRA), a leading global browser and AI agent company, today announced its upcoming browser-AI upgrades to its free browser portfolio that will complement its premium Opera Neon AI browser for advanced users. Opera is a browser expert with more than 30 years of experience in building superior products actively chosen by hundreds of millions of monthly active users. Over the past years, Opera has combined accelerating revenue growth and healthy profitability, with rapidly expanding browser AI capabilities at no charge to i

    10/3/25 9:18:00 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    SEC Filings

    View All

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

    9/18/23 10:40:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAYBUE issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug DAYBUE (ORIG-1) with active ingredient TROFINETIDE has changed to 'Approval' on 03/10/2023. Application Category: NDA, Application Number: 217026, Application Classification: Type 1 - New Molecular Entity

    3/13/23 10:37:07 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14C filed by Healthcare Triangle Inc.

    PRE 14C - Healthcare Triangle, Inc. (0001839285) (Filer)

    10/2/25 5:00:01 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 424B5 filed by Chijet Motor Company Inc.

    424B5 - Chijet Motor Company, Inc. (0001957413) (Filer)

    10/2/25 10:58:18 AM ET
    $CJET
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Nokia Corporation Sponsored

    6-K - NOKIA CORP (0000924613) (Filer)

    10/2/25 6:01:09 AM ET
    $NOK
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Leadership Updates

    Live Leadership Updates

    View All

    Guy Sucharczuk Inducted into Cable TV Pioneers Class of 2025

    Inclusion in select group of inductees honors his long career of innovation in access networks CommScope (NASDAQ: COMM), a global leader in network connectivity, announced the induction of Guy Sucharczuk, senior vice president and president of CommScope's Access Network Solutions business, into the Cable TV Pioneers class of 2025. This year's inductees included leaders in broadband, new media, technology, distribution and related fields who have made significant contributions to the industry. Sucharczuk's induction acknowledges his long career in developing breakthrough cable technologies for several companies, starting with Aurora Networks, the optical transmission company he founded i

    9/29/25 8:00:00 AM ET
    $COMM
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

    Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga Rameswamy as Chief Technology Officer, effective September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, where he served as the Vice President and Global Head of Digital Health Platforms. "Naga's deep background in digital health and connected device innovation makes him an ideal fit for Inogen as we continue to expand our technology leadership," said Kevin Smith, President and Chief Executive Officer of Inogen, "His ability to integrate software, data, and devices to improve user experiences will be instrume

    9/25/25 4:05:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    Chijet Motor Company Taps Blockchain Veteran Jason Miller as COO to Spearhead Crypto Treasury Overhaul and Capitalize on Surging Digital Asset Growth

    New York, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Chijet Motor Company, Inc. (NASDAQ:CJET) ("Chijet" or the "Company") today announced the appointment of Jason Miller as Chief Operating Officer (COO), effective immediately, to spearhead the Company's transition into the digital currency era. This move positions the Company to integrate major cryptocurrencies such as Bitcoin (BTC), Ethereum (ETH), and Solana (SOL) into its balance sheet. Miller's expertise will drive enhanced financial resilience, optimized asset allocation, and participation in the decentralized finance (DeFi) ecosystem, aligning with the accelerating institutional adoption of digital assets. Miller possesses more than two dec

    9/19/25 7:15:00 AM ET
    $CJET
    Auto Manufacturing
    Industrials

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Financials

    Live finance-specific insights

    View All

    1847 Holdings Expects to Resume Trading on OTC Pink Limited Tier

    NEW YORK, NY, Oct. 03, 2025 (GLOBE NEWSWIRE) -- 1847 Holdings LLC ("1847" or the "Company") (Previous Ticker: EFSH), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle market businesses, today announced that it expects to begin trading on the OTC Pink Limited tier of OTC Markets Group Inc. within the next one-to-four business days, subject to FINRA's review of its requested trading symbol. Following the expected commencement of trading on the OTC Pink Limited tier, the Company intends to further enhance its market visibility by promptly transitioning to the OTCID. 1847's ultimate objective is to relist on a senior U.S. exchange as soon

    10/3/25 3:15:00 PM ET
    $EFSH
    Professional Services
    Consumer Discretionary

    Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

    GREENFIELD, Ind., Oct. 1, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its third quarter 2025 financial results on Wednesday, November 5, 2025. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-and-presentations/de

    10/1/25 8:00:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Reports Results for Fourth Quarter & Fiscal Year Ended March 31, 2025

    Transformative Year Reduced Operating Costs, Launched New Products and Improved Financial Position Beneficient is Positioned to Capitalize on Adjacent Market Growth Opportunities DALLAS, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today reported its financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Commenting on the fiscal 2025 results, Beneficien

    9/29/25 5:15:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Frontier Communications Parent Inc.

    SC 13D/A - Frontier Communications Parent, Inc. (0000020520) (Subject)

    12/12/24 4:15:11 PM ET
    $FYBR
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $AEHR
    $AIMD
    $AMBO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care